Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Nature Communications|April 17, 2021
DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell deathHeng Boon Low, Zhen Lim Wong, Bangyuan Wu, et al.
NPJ Precision Oncology|April 16, 2026
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancersJie Qing Eu, Nur Afiqah Binte Mohamed Salleh, Jayshree Hirpara, et al.
Cancers|October 28, 2023
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)Yvonne L E Ang, Xiaotian Zhao, Thanyanan Reungwetwattana, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057HKeith C Bible, Vera J Suman, Julian R Molina, et al.
Frontiers in Oncology|May 30, 2024
Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unitRobert John Walsh, Rebecca Ong, Seng Wee Cheo, et al.
Cancer Discovery|September 29, 2020
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid TumorsTimothy A Yap, David S P Tan, Angelika Terbuch, et al.
Plos One|October 8, 2016
Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced NeuropathyRaghav Sundar, Anand D Jeyasekharan, Brendan Pang, et al.
Nature Communications|May 15, 2023
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinomaDarren Wan-Teck Lim, Hsiang-Fong Kao, Lisda Suteja, et al.
Targeted Oncology|June 14, 2022
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis InhibitorsJoan R E Choo, Yi-Hua Jan, Samuel G W Ow, et al.
Nature Communications|May 1, 2020
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationLi Ren Kong, Richard Weijie Ong, Tuan Zea Tan, et al.
Pageof 25